Literature DB >> 12725355

The changing epidemiology of vancomycin-resistant enterococci.

Kwan Kew Lai1, Sally A Fontecchio, Anita L Kelley, Stephen Baker, Zita S Melvin.   

Abstract

OBJECTIVE: To determine the distribution of vancomycin-resistant enterococci (VRE) cases in our hospital and those from outside of our hospital from 1993 through 1998.
METHODS: Weekly rectal surveillance was instituted whenever there were two or more cases present in the units. Cases were divided into acquired in our hospital, acquired outside of our hospital (VRE positive after and within 72 hours of admission, respectively), and indeterminate. Hospital cases were attributed to the originating ward or intensive care unit (ICU) if patients were noted to be positive within 72 hours of transfer.
RESULTS: From 1993 to 1998, the rate of VRE per 1,000 admissions increased threefold, from 3.2 to 9.8, for the hospital. VRE cases acquired outside of the hospital increased by approximately 5% per year (r = 0.87; P = .03). The rate of VRE per 1,000 admissions increased 1.7-fold in the ICUs and 3.6-fold in the wards. The ICUs had an average of 75.3 cases per year, with the number of new cases per year increasing by approximately 9 (r = 0.80; P = .028). In the wards, there were an average of 22.0 new cases per year, with a slight upward trend of 3 additional new cases per year (r = 0.69; P = .64). There was a highly significant increasing linear trend (P = .0007) for VRE colonization and infection.
CONCLUSION: Although VRE still predominate in the ICUs, cases originating from outside of our hospital and the wards are becoming more common. VRE colonization remained more frequent than infection.

Entities:  

Mesh:

Year:  2003        PMID: 12725355     DOI: 10.1086/502203

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

1.  Limiting the spread of highly resistant hospital-acquired microorganisms via critical care transfers: a simulation study.

Authors:  Umanka H Karkada; Lada A Adamic; Jeremy M Kahn; Theodore J Iwashyna
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

2.  Strategic interactions in multi-institutional epidemics of antibiotic resistance.

Authors:  David L Smith; Simon A Levin; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-26       Impact factor: 11.205

3.  In vivo efficacy and pharmacokinetics of AC98-6446, a novel cyclic glycopeptide, in experimental infection models.

Authors:  William J Weiss; Timothy Murphy; Eileen Lenoy; Mairead Young
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.